Product Images Ranitidine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranitidine Hydrochloride NDC 70710-1550 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
c47f8cd0 834a 4b54 be3e 15090889017d 01
c47f8cd0 834a 4b54 be3e 15090889017d 02
This is a description of a medication containing 25mg of ranitidine hydrochloride in a 1mL aqueous solution. It includes 5mg of phenol as a preservative and uses monobasic potassium phosphate and dibasic sodium phosphate as buffers. The medication should be used as soon as possible after opening and should be stored between 4°C and 25°C (39°F to 77°F) with permitted excursions to 30°C (86°F). The medication should be protected from light and discarded within 24 hours of opening. This medication is not for direct infusion and is distributed by Zydus Pharmaceuticals (USA) Inc.*
c47f8cd0 834a 4b54 be3e 15090889017d 03
This is a pharmacy bulk package of Ranitidine Injection USP used to treat stomach ulcers, acid reflux, and other gastrointestinal conditions. Each 40 mL vial contains 1000 mg of Ranitidine with a concentration of 25 mg/mL. The package must be stored between 4℃ and 25℃ and should be used as soon as possible after opening. Discard any unused portion within 24 hours of the initial entry. It is manufactured by Liva Pharmaceuticals in Vadodara and distributed by Zydus Pharmaceuticals in Pennington, New Jersey.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.